- Home
- IRTC
as 07-26-2024 4:00pm EST
iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company's portfolio includes ambulatory cardiac monitoring services on a platform, called the Zio service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for several days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States.
Upcoming Earnings Alert:
Get ready for potential market movements as iRhythm Technologies Inc. IRTC prepares to release earnings report on 01 Aug 2024.
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | San Francisco |
| Market Cap: | 3.2B | IPO Year: | 2016 |
| Target Price: | $127.38 | AVG Volume (30 days): | 304.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.23 | EPS Growth: | N/A |
| 52 Week Low/High: | $70.24 - $124.12 | Next Earning Date: | 08-01-2024 |
| Revenue: | $513,174,000 | Revenue Growth: | 19.35% |
| Revenue Growth (this year): | 20.86% | Revenue Growth (next year): | 18.09% |
Stock Insider Trading Activity of iRhythm Technologies Inc. (IRTC)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Turakhia Minang | IRTC | EVP, CMO & CSO | Jul 2 '24 | Sell | $105.65 | 1,404 | $148,332.60 | 27,255 | SEC Form 4 |
| Rosenbaum Marc W. | IRTC | Chief Accounting Officer | Jun 3 '24 | Sell | $88.91 | 510 | $45,344.10 | 8,174 | SEC Form 4 |
| Shrishrimal Sumi | IRTC | EVP, Chief Risk Officer | Jun 3 '24 | Sell | $88.91 | 1,131 | $100,557.21 | 23,298 | SEC Form 4 |
| Patterson Chad | IRTC | Chief Commercial Officer | Mar 4 '24 | Sell | $111.14 | 1,077 | $119,697.78 | 39,865 | SEC Form 4 |
| Blackford Quentin S. | IRTC | President and CEO | Mar 4 '24 | Sell | $111.14 | 4,221 | $469,121.94 | 175,794 | SEC Form 4 |
| Murphy Patrick Michael | IRTC | CBO and CLO | Mar 4 '24 | Sell | $111.14 | 1,525 | $169,488.50 | 47,437 | SEC Form 4 |
| Turakhia Minang | IRTC | EVP, CMO & CSO | Mar 4 '24 | Sell | $111.14 | 943 | $104,805.02 | 28,659 | SEC Form 4 |
| Wilson Daniel G. | IRTC | EVP, Corp Dev Inv Rel | Mar 4 '24 | Sell | $111.14 | 2,452 | $272,515.28 | 30,515 | SEC Form 4 |
| Bobzien Brice | IRTC | Chief Financial Officer | Mar 4 '24 | Sell | $111.14 | 1,401 | $155,707.14 | 25,800 | SEC Form 4 |
| Day Mark J. | IRTC | Chief Technology Officer | Mar 4 '24 | Sell | $111.14 | 3,248 | $360,982.72 | 61,164 | SEC Form 4 |
| Shrishrimal Sumi | IRTC | EVP, Chief Risk Officer | Mar 4 '24 | Sell | $111.14 | 723 | $80,354.22 | 24,429 | SEC Form 4 |
| Murphy Patrick Michael | IRTC | CBO and CLO | Feb 28 '24 | Sell | $121.96 | 7,615 | $928,725.40 | 48,962 | SEC Form 4 |
| Day Mark J. | IRTC | Chief Technology Officer | Feb 28 '24 | Sell | $121.96 | 1,475 | $179,891.00 | 64,412 | SEC Form 4 |
| Blackford Quentin S. | IRTC | President and CEO | Feb 28 '24 | Sell | $121.96 | 24,701 | $3,012,533.96 | 180,015 | SEC Form 4 |
| Wilson Daniel G. | IRTC | EVP, Corp Dev Inv Rel | Feb 28 '24 | Sell | $121.96 | 1,261 | $153,791.56 | 32,967 | SEC Form 4 |
| Wilson Daniel G. | IRTC | EVP, Corp Dev Inv Rel | Jan 2 '24 | Sell | $103.31 | 7,218 | $745,691.58 | 26,629 | SEC Form 4 |
| Murphy Patrick Michael | IRTC | CBO and CLO | Dec 5 '23 | Sell | $88.82 | 1,686 | $149,750.52 | 30,751 | SEC Form 4 |
| Blackford Quentin S. | IRTC | President and CEO | Jun 6 '23 | Buy | $102.27 | 9,755 | $997,643.85 | 128,510 | SEC Form 4 |
Latest iRhythm Technologies Inc. News
IRTC Breaking Stock News: Dive into IRTC Ticker-Specific Updates for Smart Investing
Simply Wall St.
a day ago
Investors might be losing patience for iRhythm Technologies' (NASDAQ:IRTC) increasing losses, as stock sheds 3.8% over the past week
GlobeNewswire
8 days ago
iRhythm Technologies to Report Second Quarter 2024 Financial Results on August 1, 2024
MT Newswires
11 days ago
Truist Lowers Price Target on iRhythm Technologies to $134 From $145, Maintains Buy Rating
MT Newswires
12 days ago
Morgan Stanley Cuts Price Target on iRhythm Technologies to $130 From $135, Keeps Overweight Rating
TipRanks
12 days ago
Oppenheimer Says These Smidcap Stocks Are Favorite Summer Picks
Argus Research
22 days ago
Daily – Vickers Top Buyers & Sellers for 07/05/2024
Barrons.com
a month ago
Did Your Heart Just Skip a Beat? Your Watch Already Knows That and More.
Investing.com
a month ago
Street calls of the week: Micron downgrade, upgrade for Kroger
Compare IRTC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IRTC iRhythm Technologies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.